İNTRAKRANİYAL PATOLOJİLERİN İNTRAOPERATİF MANYETİK REZONANS GÖRÜNTÜLEME İLE DEĞERLENDİRİLMESİ VE TAKİPLERİNDEKİ DENEYİMLERİMİZ


Thesis Type: Expertise In Medicine

Institution Of The Thesis: Gazi University, Tıp Fakültesi, Dahili Tıp Bilimleri, Turkey

Approval Date: 2023

Thesis Language: Turkish

Student: LEYLA MIRZAYEVA

Supervisor: Murat Uçar

Open Archive Collection: AVESIS Open Access Collection

Abstract:

Today, Io MRI is used for various purposes, such as the excision of primary brain tumors, providing biopsy cannula access to the target tissue, epilepsy surgery, and electrode placement for deep brain stimulation in Parkinson's disease. Io MRIguided surgery allows the surgeon to increase the resection rate in patients with brain tumors by preserving the eloquent cortex and eloquent areas. This is associated with prolonged survival and improved quality of life, especially in patients with glioma. In this study, we aimed to investigate the effect of Io MRI on extend of resection (EOR) in patients with primary brain tumors who underwent Io MRI during surgery. Another research subject was the impact of the preoperative MRI diagnosis on the surgeon's decision to proceed with the operation if residual tissue was detected on Io MRI. We also examined the effect of Io MRI, EOR, and tumor location on overall and progression-free survival in gliomas, the most common malignant primary brain tumor in adults. One hundred ninety-nine patients who were operated on for primary intracranial neoplasms in the Gazi University Faculty of Medicine Department of Neurosurgery were included in the study. One hundred and seventy-one patients constituted the Io MRI group, and 28 patients with a diagnosis of glioma constituted the control group, which operated with conventional neuronavigation. It was observed that Io MRI increased EOR in patients diagnosed with glioma, meningioma, and pituitary adenoma, respectively. Since optimal resection could not be achieved in 45 patients with glioma who underwent Io MRI, it was decided to continue the operation, and the GTR rate increased from 33,6% to 49,6%. It has been shown that Io MRI is associated with increased overall survival and progression-free survival in patients with glioma compared to the control group. Since the adjuvant CRT response is weak and there is a risk of malignant transformation in LGG, the surgeon tried to provide the widest possible resection by applying a more aggressive technique. In our study, the EOR of the cases with a preliminary diagnosis of HGG was lower than those with LGG due to the aforementioned reason. In conclusion, the benefits of Io MRI have been demonstrated in the excision of various intracranial tumors such as gliomas, meningiomas, pituitary neoplasms, and schwannoma. These impressive clinical results have led to the technical development and widespread acceptance of costly and laborious intraoperative imaging modalities. Gliomas are the group of tumors in which Io imaging is most required. In this study, it has been investigated and proven that the high-field MRI device provides both reducing the tumor burden and improving the progression-free survival, as well as providing the surgeon for maximal and optimal resection in the first operation. Future studies are expected to include histopathological diagnoses based on molecular and genetic profiles and to conduct studies with larger sample sizes and more homogeneous case groups with Io MR.